Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Baxter
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for CAM2038


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug CAM2038?

CAM2038 is an investigational drug.

There have been 10 clinical trials for CAM2038. The most recent clinical trial was a Phase 3 trial, which was initiated on July 21st 2020.

The most common disease conditions in clinical trials are Opioid-Related Disorders, Substance-Related Disorders, and Disease. The leading clinical trial sponsors are The Emmes Company, LLC, Braeburn Pharmaceuticals, and National Institute on Drug Abuse (NIDA).

There is one US patent protecting this investigational drug and nineteen international patents.

Recent Clinical Trials for CAM2038
TitleSponsorPhase
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-studyNational Institute on Drug Abuse (NIDA)Phase 3
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-studyThe Emmes Company, LLCPhase 3
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-studyThe EMMES CorporationPhase 3

See all CAM2038 clinical trials

Clinical Trial Summary for CAM2038

Top disease conditions for CAM2038
Top clinical trial sponsors for CAM2038

See all CAM2038 clinical trials

US Patents for CAM2038

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
CAM2038 ⤷  Sign up for a Free Trial Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof The Regents of the University of California (Oakland, CA) ⤷  Sign up for a Free Trial
CAM2038 ⤷  Sign up for a Free Trial Methods and devices to reduce damaging effects of concussive or blast forces on a subject TBI INNOVATIONS, LLC (Richmond, IN) THORNHILL RESEARCH, INC. (Toronto, Ontario, CA) ⤷  Sign up for a Free Trial
CAM2038 ⤷  Sign up for a Free Trial Pharmaceutical formulations GW Pharma Limited (Cambridge, GB) ⤷  Sign up for a Free Trial
CAM2038 ⤷  Sign up for a Free Trial Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse Acura Pharmaceuticals, Inc. (Palatine, IL) ⤷  Sign up for a Free Trial
CAM2038 ⤷  Sign up for a Free Trial Tamper-resistant pharmaceutical compositions of opioids and other drugs COLLEGIUM PHARMACEUTICAL, INC. (Canton, MA) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for CAM2038

Drugname Country Document Number Estimated Expiration Related US Patent
CAM2038 European Patent Office EP2981556 2033-04-02 ⤷  Sign up for a Free Trial
CAM2038 World Intellectual Property Organization (WIPO) WO2014165513 2033-04-02 ⤷  Sign up for a Free Trial
CAM2038 Australia AU2017260251 2036-05-03 ⤷  Sign up for a Free Trial
CAM2038 Canada CA3022932 2036-05-03 ⤷  Sign up for a Free Trial
CAM2038 China CN109414220 2036-05-03 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Baxter
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.